Publication | Open Access

Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials

VaccinationVaccine SafetyVaccinologyImmunologyVirologyVaccine EfficacyInfluenza VaccineCovid-19MedicineEgg-based Vaccine ProductionInfluenza Vaccines